Skip to content

Comparative Effects of Theragun Percussion Therapy and Compression Therapy in The Patients With Migraine

Comparative Effects of Theragun Percussion Therapy and Compression Therapy on Pain, Neck Range of Motion and Quality of Life in The Patients With Migraine

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06504537
Enrollment
50
Registered
2024-07-16
Start date
2024-01-01
Completion date
2024-08-30
Last updated
2024-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Keywords

neck stiffness, headache, PNF, strteching, compression therapy

Brief summary

The aim of this study is to compare the effects of Theragun Percussion therapy and Compression Therapy on pain, neck range of motion and quality of life in the patients with Migraine

Detailed description

Migraine is a type of unilateral headache characterized by recurrent attacks of moderate to severe pulsating pain which common symptoms include increased sensitivity to light, noise, nausea and vomiting. Mechanical scalp compression is the most commonly used for temporary relief of migraine pain that originates from dilated blood vessels in the scalp. Many percussive therapy devices are used for relax and soothe sore muscles as Theragun helps in instant relief migraine pain. It will be a Single blinded randomized clinical trial. Non-probability convenience sampling technique will be used to recruit 56 participants of 18 to 50 years of age from Riphah Rehabilitation Care Centre and Sir Ganga Ram Hospital, Lahore. The participants will be then randomly assigned into two equal groups through random number generation table. In Group A, Percussion Therapy will be applied by Theragun device for 25 minutes in each session along with Routine Physical Therapy Treatment for 20 minutes. In Group B, the Compression Therapy will be applied by migraine relief Gel Cap which works as Compression device for head for 25 minutes in each session along with Routine Physical Therapy Treatment for 20 minutes. The treatment will be given for 5 times per week for 6 weeks. Outcome measures for pre and post evaluation will be Visual Analogue Scale (VAS) for pain assessment, Migraine Screening Quality of life Questionnaire (MS-Q) for quality of life, Neck Disability Index (NDI) for neck disability, Bubble Inclinometer for neck range of motion. The data will be analyzed using SPSS version 24.

Interventions

OTHERTHERAGUN PERCUSSION THERAPY

In Group A, Patients will receive Theragun Percussion therapy along with routine Physical Therapy Treatment. The range of motion of lateral flexion and forward flexion will take by using a bubble inclinometer. Then the patient will place in a sitting position with the shoulder area exposed. Percussion therapy by using the Theragun device will give by a specific order. Treatment will start with the percussion head applied at the origin and insertion heads of the trapezius, Rhomboid and scalene muscle for 3-4 minutes each. Following this the percussive Theragun applicator will applied with circular strokes along the length of the muscle for 3 minutes. The pressure of application will adjust to the subject's tolerance.

In Group B, Compression therapy will be administered to the patients by migraine relief gel cap for 25 minutes during migraine attacks. The cap will store in a freezer (15-18°C). At the onset of the migraine attacks, patients wore the cap and used it. We will choose 25 minutes as the time for application of the gel cap based on the results of two published studies.(23) Headache severity will measured by Visual Analogue Scale and pain relief will measured on a similar scale. Analgesic treatment will not take within 25 minutes after the onset of cold therapy. If patients did not experience adequate relief from the headache, we will allow them to use analgesics 25 minutes after the onset of cold therapy. The routine physical treatment will be same as in group A.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

the study would be single blinded as the assessor of the study would be kept blind.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Both Genders 2. 18 to 65 years' old 3. Migraine without Aura 4. Headache with nausea or vomiting and light/sound sensitivity 5. Unilateral Headache from past 3 months at least once a week 6. ICHD-3 Criteria of migraine

Exclusion criteria

1. Congenital Condition of cervical spine 2. Inability of neck to perform flexion-rotation test 3. Meningitis, deep vein thrombosis 4. other-type of headache 5. Headache attributed to trauma or injury to neck

Design outcomes

Primary

MeasureTime frameDescription
International Classification of Headache Disorders (ICHD-3)6 weeksUsing ICHD-3 can aid first-visit patients by providing extended likely categories and removing the requirement for underlying cause disease remission before headache diagnosis. One of the ICHD-3 criteria for diagnosing migraines is * the quality of the pulsating pain. * Moderate to severe levels of pain * Made worse by day-to-day ordinary activities

Secondary

MeasureTime frameDescription
Neck Disability Index (NDI)6 weeksThe Neck Impairment Index is the most commonly used questionnaire to evaluate neck pain impairment (NDI) The NDI consists of ten questions: two ask about symptoms, the remaining question concerns concentration, and the other seven center on functional tasks. The 20-item test looks at four areas: activities of daily living, pain severity, emotion/cognition, and neck function. These categories show how a patient's neck pain condition affects their ability to operate both physically and emotionally
Migraine Screening Quality of Life Questionnaire (MS-Q)6 weeksThe five-item migraine screen questionnaire, or MS-Q, was developed for use in research and clinical settings including occupational medicine and the general public as well as occupational medicine practitioners. The questionnaire is based on the diagnostic criteria for migraines published by the International Headache Society (IHS). This structured questionnaire consists of five items, each with a yes/no binary response option. For every NO response, a score of 0 is given, and for every YES response, a score of 1\. A cut-off point of ≥4 indicates a migraine case and a total score of 5 indicates this.
Visual Analogue Scale (VAS)6 weeksThe VAS for attention was used to measure the participants' self-reported level of difficulty in maintaining focus. The participants were instructed to write a mark on the line that most accurately expressed their feelings regarding the challenge of paying attention.rating fron 0 to 10. 0 for no pain and 10 for worst pain.

Other

MeasureTime frameDescription
Bubble Inclinometer6 weeksRange of-motion is measured with a Bubble Inclinometer. Position the inclinometer near the joint that has to be measured; rotate the dial until the scale reaches zero; proceed to move the joint over its range; and finally, determine the distance traveled directly from the dial.

Countries

Pakistan

Contacts

Primary ContactHira Jabeen
hira.jabeen@riphah.edu.pk0323-4116506
Backup ContactRabia Amjad, DPT
rabiamughal614@gmail.com0322-7833519

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026